MedTech Alliance Program Spring Meeting

Similar documents
Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV

Scripps Florida. Accelerating Discoveries, Saving Lives. Presentation to the Urban Land Institute November 4, 2011

PANEL DISCUSSION & ROUNDTABLES

Celebrating International Women's Day Friday, March 8, :30am-1:00pm

MENTORS REGULATORY AFFAIRS. Christophe AMIEL Head of Medical Device & Digital, Voisin Consulting Life Sciences STRATEGY/BUSINESS

Collaborating with the Office of Technology Transfer

TRANSLATIONAL SCIENCE

Technology Leadership Course Descriptions

Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research

Biotech Concerto #6 Investment Process December 2008

Comprehensive Research Services

Untying the Gordian Knot:

Clark A.D. Wilson. Senior Counsel. Practices. Industries

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Global Source Ventures, LLC Introduction. Antonius Schuh Managing Partner Stephen Zaniboni Managing Partner

HFMA January CFO Forum

Investor s Meeting. Managed by. May 12, Estancia La Jolla Hotel & Spa

Utrecht Region. A key role in the Netherlands medical technology industry. Why locate your medical technology company in the Utrecht Region?

Omeros Raises More Than $63 Million in Financing

Agenda. Genesys Capital Partners. The Opportunity. Our Approach

Data Sciences Entrepreneurship class

Wael Al-Delaimy MD, PhD. President, Society for Advancement of Science and Technology in the Arab World

Thelander 2016 PRIVATE COMPANY YEAR END MERIT INCREASE PITCHBOOK REPORT. J. Thelander Consulting

Life Sciences Queensland announces latest LSQ Ambassadors

JOHN JACK R. TUPMAN, JR CURRICULUM VITAE

NIHR ROADSHOW FOR MEDTECH SMES

OPEN SESSION. *Some of the business to be conducted is authorized by the N.C. Open Meetings Law to be conducted in closed session.

Inclusion Women at the Forefront of STEM

Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development

Research Patents in Biotech SMEs

Kandace P. Watson Partner

Medtech Slowdown. Life sciences venture capital funding lagged behind other industries, declining 10% in 4Q13 and 1% in 2013 over last year

San Diego. March 2, American College of Surgeons Surgical Health Care Quality Forum. American College of Surgeons

Patent. Fish &Richardson

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.

Curriculum Vita. Paul H. Keckley, Ph.D. Career Focus: Expert on health system transformation. Career History: Current:

PROGRAM ANNOUNCEMENT. New Jersey Institute of Technology. MSPhM Systems Engineering. Newark. Fall 2008

Triton Technology Fund

Mara H. Rogers, Partner Norton Rose Fulbright

BREAKTHROUGH CONVENTION SUMMARY JUNE SAN DIEGO CONVENTION.BIO.ORG #BIO2017

Flagship Pioneering Fellows Progam

Course Goals/Objectives. The course has five objectives:

Outside Business Activities Reviews, Approval and Monitoring Wednesday, November 11 3:30 p.m. 4:30 p.m.

ACS Entrepreneurial Summit 2014 October 13-14, 2014

GOALS FOR PRESENTATION

the SPD company Dr Clive Simon, Principal, The SPD Company.

The Three Lines of Defense: Risk Management Supervision, Compliance and Internal Audit Monday, May 21 3:00 p.m. 4:00 p.m.

Brief Bios Candidates for Vice President for Administration and Finance

Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs

Michael R. McAlevey, Chief Corporate and Securities Counsel, General Electric Co.

HealthTech: What does it mean for compliance?

Jean W. Frydman Partner

Speaker Profile. 1 st ASBC Conference February 2019 Disruptive SBC strategies for the future of Africa

PRESENTERS >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

SME Policy Design and Evaluation: Insights from Research on Entrepreneurship and Innovation

QI Comes of Age: Health Reform Accelerates

Fall State of the Industry Report UF SID MARTIN FLORIDA BIODATABASE

The Complexities of Mixed Use

Management Bios. Michael P. Norcio, Chairman and CEO

LISA TILTON-McCARTHY

TTC Introduction Meeting at: Carmiel, October 2014

2015 Real Estate Industry Update A landscape for change: Transforming for the future

THE BIOMEDICAL ENGINEERING TEACHING & INNOVATION CENTER. at Boston University s College of Engineering

Dean A. Connor. President & Chief Executive Officer, Sun Life Financial

BOARD OF DIRECTORS. PETER WEHRLY Chair

Management Team. Bruce C. Cozadd Chairman and Chief Executive Officer

Challenging Times: Sustaining Your Business While Waiting for Financing. January 14, 2009

Dynamic Cities and Creative Clusters

Supervision of Outside Business Activities (OBAs) and Private Securities Transactions Wednesday, November 9 3:30 p.m. 4:30 p.m.

THE AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION RECOMMENDATIONS REGARDING QUALIFICATIONS FOR

WIRED BIOSCIENCE INSTITUTE. February 5-6, 2008 Winston Salem, North Carolina

Partnering with Universities for Deal Flow

Wolfpack Investor Network. Investing in Our University s Best and Brightest

when it comes to law OPERATIONAL EXPERIENCE Soody Tronson Managing Founder Phone Fax Woodside / Santa Clara

MCGILL CENTRE FOR THE CONVERGENCE OF HEALTH AND ECONOMICS (MCCHE)

Ronald Lee Davidson SW 40th Moore, Oklahoma Phone: (405) Fax: (405)

NEWS RELEASE. Life sciences companies tout their expertise in India

Health Care Expert Panel Bios

Commercialization Strategies that Work

NVESTOR. 1,400+ Attendees. 2,700+ Partnering Meetings. 768 Companies. 700 Registered Investors. 158 Company Presentations

2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market

Women in Innovation: Business and Commerce

WILSON SONSINI GOODRICH & ROSATI

NYC Tech Connect. Connecting the Dots Between Entrepreneurship and Innovation. Melinda Thomas

Rick Legleiter Appointed Chief Executive Officer, Chairman Succession and Board Renewal Process

Webinar: A Northwest Vision for 2040 Water Infrastructure. Innovative Pathways, Smarter Spending, Better Outcomes

Tuesday, December 4, PM to 8PM. Location:

Health & Social Care Industrial Innovation

JURY BOARD BUSINESS/INVESTMENT. Pascal BECACHE Founding President, PBS, Healthcare Industry STRATEGY/BUSINESS

Dr Gary Wilson Partner. Our philosophy. HGF Limited

Rising to the Innovation Challenge

Crack the Code: Demystify the Success Factors for Career Development

Managing Intellectual Property Assets: The NIH OTT Perspective

THE STARTUP REVOLUTION WHAT ARE YOUR RIGHTS AND HOW TO PROTECT THEM

DISCOVERY LECTURE SERIES

Teresa V. Pahl Partner

Virtual Journal Club. Guest Faculty. Definitions

INTELLECTUAL PROPERTY POLICY

Conflict of Interest and Medical Innovation: Ensuring Integrity while Facilitating Innovation in Medical Research A Workshop

A Research and Innovation Center

Transcription:

Oregon Health & Science University Presents: MedTech Alliance Program Spring Meeting OHSU will be hosting its second MedTech Alliance program meeting on Wednesday, May 6 from 5:00PM to 7:30PM. Community partners from Ater Wynne LLP will lead moderated mini-discussions on OHSU technologies that include the inventors, technology managers, and collaborators. The MedTech Alliance program is a platform for investors, industry representatives, and community partners to stay up-to-date on early stage collaboration and investment opportunities at OHSU. The goal of the MedTech Alliance program is to facilitate collaborations and investment opportunities in order to advance OHSU innovations. Click HERE for more information. Technologies highlighted on the evening of May 6th will include: Antithrombotic drugs without bleeding side effects (Andras Gruber, MD) Bioabsorbable dural clips (Neil Roundy, MD & Rachel Dreilinger) Accurate in-home collection of blood samples (Andrew Chitty, MBA; Dorota Shortell, MSME; Trina Voss) New generation of dental composites (Carmem Pfeifer, DDS, PhD) Excellent food, drink, and company will be provided. Register HERE. *Registration in advance is required in order to participate.* Please direct questions to Trish Pruis: pruist@ohsu.edu. Agenda 5:00PM-5:30PM - Arrival & Networking 5:30PM-7:00PM Introduction & Moderated Mini-Discussions 7:00PM-7:30PM Networking with Presenters

Participants Andrew Chitty, OHSU Inventor Andy Chitty is the University Shared Resources (USR) Program Director at OHSU. The USR program manages the portfolio of OHSU cores to optimize scientific and financial operations. Cores are advanced technology centers that provide access to cutting edge facilities and expertise to campus investigators. Prior to getting his MBA, Andy spent sixteen years as a scientific equipment designer and manufacturer at Optimize Technologies, where he was in charge of designing products for various industries, including: liquid chromatography, mass spectrometry, clinical diagnostics, bio-defense and nuclear pharmacy. At Optimize, he also served as Senior Manager over R&D, engineering, sales and marketing, and OEM project management. Frank Curci, Moderator Frank X. Curci is a technology and intellectual property attorney and a Partner at Ater Wynne LLP law firm. He represents bioscience companies, research institutions, and high technology companies concerning a wide range of intellectual property and technology matters, including patent/ip licensing, multi-party technology collaborations, and the overall development, protection, commercialization and other uses an entity s IP rights. He is a member of the Board of Directors of the Cancer Research & Biostatistics Institute, a Seattle-based nonprofit bioscience institute. Dan Dorsa, OHSU Leadership Daniel Dorsa, PhD, joined OHSU in 2001 as Vice President for Research. In this role, he administers and coordinates academic research and ensures compliance at OHSU s three schools and several free-standing research institutes and centers. He works closely with the leaders of those entities to set the agenda for building OHSU s research capacity. As senior vice president for research, Dr. Dorsa oversees several NIHfunded research entities including the Oregon Clinical and Translational Research Institute and the Oregon National Primate Research Center. In these roles, Dr. Dorsa also serves as the key interface between investigators and OHSU s Executive Leadership Team and represents the interests of the research community at the highest level. Rachel Dreilinger, Collaborator & Inventor Rachel Dreilinger is a biomechanical engineer and entrepreneur with professional experience in consulting, startups, mechanical design, medical & surgical device design and lab automation & robotics. Rachel is Co- Founder and CEO of NeuraMedica, a neurosurgery device company founded to commercialize a reabsorbable dural clip OHSU technology. She received her B.S. degree in Bioengineering from the University of California, San Diego (UCSD) in 1999.

Andras Gruber, OHSU Inventor Andras Gruber, MD, is the founder of Aronora, Inc., which is an OHSU spin off biotechnology company. Aronora focuses on translational research & development of innovative biological drugs that are intended for use in cardiovascular emergencies. Aronora has been supported by sustained and significant competitive SBIR grant funding since 2009. The company was ranked by dollar amount #13 in 2011, #10 in 2012 and #9 in 2013 among all NIH research grant awardees in Oregon. Prior to joining OHSU in 2004, Dr. Gruber held faculty appointments at The Scripps Research Institute and Emory University, and also worked in executive medical and scientific positions for small biotechnology companies. His accomplishments include the first description of a rare disease (acquired protein C deficiency), 3 of 4 issued patents reduced to medical practice and one in development, and direct contribution to the discovery and/or development of FDA-approved biomedical products and devices. Akana Ma, Moderator Akana K.J. Ma is a Partner at Ater Wynne LLP. He offers clients from around the world practical, creative solutions to business and legal issues involving different cultures, legal systems, and business. He chairs Ater Wynne s Global Trade Group. Akana works with a variety of bioscience and medical device companies conducting business in the global marketplace to help structure joint ventures, bioscience research and marketing collaborations, distribution of medical devices; license and protect technology and comply with foreign laws and regulations, among many services for biotechnology companies. Carmem Pfeifer, OHSU Inventor Carmem Pfeifer, DDS, PhD, is an Assistant Professor in the School of Dentistry at OHSU. Dr. Pfeifer s research, which is highly collaborative, focuses on biomaterials and biomechanics for restorative dentistry. Carmem has been awarded grants from the Medical Research Foundation and the NIH to develop new polymeric materials for dental applications. Her grants are geared towards the development and enrichment of dental student research programs, as well as for developing a new generation of dental composites. Dr. Pfeifer holds joint appointments in the Pediatric Dentistry Dept. at OHSU, as well as the Craniofacial Biology Dept. in the School of Dental Medicine at the University of Colorado-Denver. Trish Pruis, OHSU Business Development Trish Pruis, PhD, is a Business Development Associate in the Technology Transfer & Business Development Office at Oregon Health & Science University (OHSU). Her key roles are to facilitate relationships with potential business partners, including pharmaceutical, biotech, and medical device companies, investors, research institutes, and other relevant partners. She is also responsible for managing OHSU's MedTech Alliance program, which is a platform for investors, industry representatives, and community partners to stay up-to-date on early stage technologies developed at OHSU. Trish's overarching goal is to support commercialization and partnership efforts at the university.

Neil Roundy, OHSU Inventor Neil Roundy, M.D. is a neurosurgeon with Oregon Neurosurgery Specialists, a private-practice group in Eugene, OR. He is also Co-Founder and Chief Medical Officer of NeuraMedica, a neurosurgery device startup to commercialize his reabsorbable dural clip technology developed at OHSU. Dr. Roundy has ongoing research projects in advanced Neuroimaging using High-Field 7 Tesla MRI; mobile technology in education and pre-operative, multispectral, high-resolution 3D modeling for simulated surgical planning. His work interests include skullbase surgery, minimally-invasive intracranial and spinal surgery and neuroendoscopy. He graduated from University of Arizona in 2007. Dorota Shortell, Collaborator & Inventor Dorota Shortell is President of Simplexity Product Development Inc. and has always had a passion for product innovation. Simplexity is an engineering design company with a unique simpler is better development philosophy that has served leading technology and bioscience firms for more than twenty years. Dorota has been leading a team of Simplexity engineers working on a joint project with OHSU researchers, physicians, and staff. Simplexity has been responsible for the engineering and design side of the project, including bringing in cross-discipline innovations and designing a product that is ready for commercialization. Dorota was recognized in 2012 by the Portland Business Journal as one of the region s top business leaders as a Forty under 40 Award winner. Trina Voss, OHSU Technology Management Trina Voss is a Technology Development Manager at OHSU, where she is responsible for licensing OHSU discoveries to bring them from lab to market. Trina is passionate about commercialization efforts that lead to improvements in human health. Prior to joining OHSU in 2010, Trina was at the USC Stevens Institute for Innovation at the University of Southern California as a licensing specialist. Trina received her Bachelor of Science degrees in Zoology and Biology, with minors in German Language and Computer Information systems at Humboldt State University. Andrew Watson, OHSU Leadership Andrew Watson, PhD, is the Director of Technology Transfer at OHSU. Dr. Watson manages the licensing, intellectual property protection, and industry collaborations aspects of the office. He is also responsible for the day-to-day management of the office and technology transfer staff as well as preparation and management of departmental budgets. He is involved in developing and implementing university policies, providing leadership in developing strategies for corporate collaborations, and serves as an OHSU spokesperson for matters relating to intellectual property, commercialization and economic impact of OHSU research. He has authored several scientific publications and technology transfer articles, and is an active member of the Association of University Technology Managers, the Licensing Executives Society and the Oregon Bioscience Association.

Location & Parking OHSU/OUS Collaborative Life Sciences Building, Rm. 3A001 2730 SW Moody Ave, Portland, OR 97201 Please park in the OHSU Schnitzer Parking Lot just north of the Collaborative Life Sciences Building (CLSB). The address for the parking lot is: 2650 SW Moody, Portland, OR. You can also enter Schnitzer Parking Lot, Portland, OR into Google maps or click on the map below.